BusinessUpdated 13 min ago
Biocon gets European Commission nod for breast cancer biosimilar

First under new tailored clinical pathway; company’s fifth oncology biosimilar approved in Europe and the US
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.



